CTRI/2020/10/028487尚未招募未知
Adverse Drug Reaction profile of Remdesivir in COVID-19 patients: A Cohort Event Monitoring Study. - CEMS
AIIMS Patna0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •2.Laboratory (RT-PCR) confirmed COVID-19.
- •3.Lung involvement confirmed with chest imaging
- •4.Hospitalized with a SaO2/SPO2<=94% on room air or Pa02/Fi02 ratio <300mgHg.
- •5.Willingness of study participant to take part in this study.
排除标准
- •3.Pregnant or breastfeeding, or positive pregnancy test in a pre-dose examination
研究者
相似试验
尚未招募
不适用
To study whether Remdesivir (an antiviral, used for the treatment of COVID - 19) is effective in COVID 19 patients with respect to complications of the disease or death.CTRI/2021/01/030385Kasturba Medical College Manipal
招募中
2 期
Evaluating the effects of remdesivir in severe COVID-19 in hospitalized patientsIRCT20151227025726N28Shahid Beheshti University of Medical Sciences120
招募中
3 期
Efficacy of Remdesivir in Comparison with Interferon Beta-1 a and Remdesivir in the Treatment of Covid 19IRCT20200721048159N4Vice Chancellor for Research and Technology of Lorestan University of Medical Sciences100
尚未招募
不适用
safety of remdesivir use in patients with impaired kidney function and covid 19 infectioCTRI/2020/12/030046DrMaulin Shah
尚未招募
不适用
A retrospective analysis to study the Effectiveness and Safety profile of Remdesivir therapy in patients who diagnosed with COVID-19CTRI/2021/01/030433Dr Vishal Shanbhag